Gr. Sarantis Zukünftiges Wachstum

Future Kriterienprüfungen 3/6

Gr. Sarantis wird ein jährliches Gewinn- und Umsatzwachstum von 12.8% bzw. 7.2% prognostiziert. Der Gewinn pro Aktie wird voraussichtlich wachsen um 12.7% pro Jahr. Die Eigenkapitalrendite wird in 3 Jahren voraussichtlich 14.7% betragen.

Wichtige Informationen

12.3%

Wachstumsrate der Gewinne

12.0%

EPS-Wachstumsrate

Personal Products Gewinnwachstum	8.2%
Wachstumsrate der Einnahmen	5.8%
Zukünftige Eigenkapitalrendite	14.6%
Analystenabdeckung	Good
Zuletzt aktualisiert	23 Sep 2024

Jüngste Aktualisierungen zum künftigen Wachstum

Recent updates

Kyriakos Sarantis Is The Vice Chairman & CEO of Gr. Sarantis S.A. (ATH:SAR) And Just Spent €118k On Shares

Feb 12

Is Gr. Sarantis S.A. (ATH:SAR) A Great Dividend Stock?

Jan 28

Will The ROCE Trend At Gr. Sarantis (ATH:SAR) Continue?

Jan 10

Who Has Been Selling Gr. Sarantis S.A. (ATH:SAR) Shares?

Dec 17

What Does Gr. Sarantis S.A.'s (ATH:SAR) Share Price Indicate?

Dec 04

Gewinn- und Umsatzwachstumsprognosen

ATSE:SAR - Zukünftige Analystenschätzungen und Finanzdaten der Vergangenheit (EUR Millions)
Datum	Umsatz	Gewinne	Freier Cashflow	Bargeld aus operativen Tätigkeiten	Durchschn. Anz. Analysten
12/31/2026	663	65	66	81	6
12/31/2025	629	55	55	74	6
12/31/2024	595	48	-4	52	6
6/30/2024	552	44	47	58	N/A
3/31/2024	517	42	50	59	N/A
12/31/2023	482	39	52	59	N/A
9/30/2023	473	37	45	52	N/A
6/30/2023	465	34	37	45	N/A
3/31/2023	455	30	25	34	N/A
12/31/2022	445	26	12	23	N/A
9/30/2022	434	27	10	25	N/A
6/30/2022	424	28	8	28	N/A
3/31/2022	415	29	14	39	N/A
12/31/2021	406	31	20	50	N/A
9/30/2021	406	34	13	42	N/A
6/30/2021	405	38	5	33	N/A
3/31/2021	399	38	5	32	N/A
12/31/2020	393	39	4	32	N/A
9/30/2020	387	39	8	34	N/A
6/30/2020	382	40	12	36	N/A
3/31/2020	376	39	9	28	N/A
12/31/2019	370	38	6	20	N/A
9/30/2019	363	36	1	15	N/A
6/30/2019	356	34	-4	11	N/A
3/31/2019	350	33	-3	11	N/A
12/31/2018	344	33	-1	11	N/A
9/30/2018	329	30	4	15	N/A
6/30/2018	314	27	10	20	N/A
3/31/2018	307	28	N/A	24	N/A
12/31/2017	300	29	N/A	28	N/A
9/30/2017	308	29	N/A	22	N/A
6/30/2017	315	29	N/A	15	N/A
3/31/2017	322	27	N/A	13	N/A
12/31/2016	329	25	N/A	10	N/A
9/30/2016	323	25	N/A	11	N/A
6/30/2016	306	23	N/A	12	N/A
3/31/2016	303	22	N/A	12	N/A
12/31/2015	279	20	N/A	12	N/A
9/30/2015	266	19	N/A	14	N/A
6/30/2015	260	17	N/A	15	N/A
3/31/2015	253	17	N/A	7	N/A
12/31/2014	248	17	N/A	9	N/A
9/30/2014	247	15	N/A	9	N/A
6/30/2014	242	14	N/A	9	N/A
3/31/2014	237	15	N/A	13	N/A
12/31/2013	236	16	N/A	17	N/A

Analystenprognosen zum zukünftigen Wachstum

Einkommen vs. Sparrate: SARDas prognostizierte Gewinnwachstum (12.8% pro Jahr) liegt über der Sparquote (2.5%).

Ertrag vs. Markt: SARDie Erträge des Unternehmens (12.8% pro Jahr) werden voraussichtlich schneller wachsen als der Markt Greek (2.7% pro Jahr).

Hohe Wachstumserträge: SARDie Erträge des Unternehmens werden voraussichtlich steigen, jedoch nicht deutlich.

Einnahmen vs. Markt: SARDie Einnahmen des Unternehmens (7.2% pro Jahr) werden voraussichtlich schneller wachsen als der Markt Greek (4.7% pro Jahr).

Hohe Wachstumseinnahmen: SARDie Einnahmen des Unternehmens (7.2% pro Jahr) werden voraussichtlich langsamer wachsen als 20% pro Jahr.

Wachstumsprognosen für den Gewinn je Aktie

Künftige Eigenkapitalrendite

Künftige Eigenkapitalrendite: SARDie Eigenkapitalrendite des Unternehmens wird in 3 Jahren voraussichtlich niedrig sein (14.7%).

Gr. Sarantis Zukünftiges Wachstum

Future Kriterienprüfungen 3/6

Wichtige Informationen

Jüngste Aktualisierungen zum künftigen Wachstum

Price target increased by 7.9% to €14.09

Price target increased by 14% to €13.93

Price target increased by 9.0% to €9.48

Price target increased by 10% to €8.50

Price target increased by 10% to €7.98

Price target decreased to €7.60

Recent updates

Executive Chairman recently bought €544k worth of stock

Price target increased by 7.9% to €14.09

First half 2024 earnings released: EPS: €0.38 (vs €0.29 in 1H 2023)

Executive Chairman recently bought €110k worth of stock

Price target increased by 14% to €13.93

Dividend increased to €0.22

Now 21% undervalued

New minor risk - Share price stability

Gr. Sarantis S.A. to Report First Half, 2024 Results on Sep 03, 2024

Price target increased by 9.0% to €9.48

Investor sentiment improves as stock rises 19%

Now 24% overvalued after recent price rise

Full year 2023 earnings released: EPS: €0.59 (vs €0.39 in FY 2022)

Gr. Sarantis S.A. to Report Fiscal Year 2023 Results on Mar 11, 2024

Price target increased by 10% to €8.50

Gr. Sarantis S.A., Annual General Meeting, Dec 20, 2023

Gr. Sarantis S.A. to Report Nine Months, 2023 Results on Nov 07, 2023

New major risk - Revenue and earnings growth

Price target increased by 10% to €7.98

First half 2023 earnings released: EPS: €0.29 (vs €0.17 in 1H 2022)

Gr. Sarantis S.A. to Report First Half, 2023 Results on Sep 11, 2023

New minor risk - Shareholder dilution

Full year 2022 earnings released

Price target decreased to €7.60

Less than half of directors are independent

Price target decreased to €7.60

Price target decreased to €7.78

First half 2022 earnings released: EPS: €0 (vs €0.29 in 1H 2021)

Gr. Sarantis S.A. to Report First Half, 2022 Results on Sep 08, 2022

An unknown buyer agreed to acquire 49% stake in ELCA Cosmetics Limited for €55.2 million.

Price target decreased to €8.48

Full year 2021 earnings: EPS misses analyst expectations

Less than half of directors are independent

Gr. Sarantis S.A., Annual General Meeting, May 24, 2022

Gr. Sarantis S.A. to Report Fiscal Year 2021 Results on Apr 29, 2022

CEO & Director recently sold €2.0m worth of stock

Capital Allocation Trends At Gr. Sarantis (ATH:SAR) Aren't Ideal

Investor sentiment deteriorated over the past week

Vice Chairman & CEO recently bought €86k worth of stock

Gr. Sarantis S.A. (ATSE:SAR) announces an Equity Buyback for 4,222,844 shares, representing 6.04% for €63.34 million.

Vice Chairman & CEO recently bought €119k worth of stock

Vice Chairman & CEO recently bought €248k worth of stock

First half 2021 earnings released: EPS €0.29 (vs €0.23 in 1H 2020)

Vice Chairman & CEO recently bought €61k worth of stock

Vice Chairman & CEO recently bought €90k worth of stock

Vice Chairman & CEO recently bought €915k worth of stock

Vice Chairman & CEO recently bought €69k worth of stock

Vice Chairman & CEO recently bought €217k worth of stock

Robust Earnings May Not Tell The Whole Story For Gr. Sarantis (ATH:SAR)

Full year 2020 earnings released: EPS €0.58 (vs €0.57 in FY 2019)

At €8.66, Is It Time To Put Gr. Sarantis S.A. (ATH:SAR) On Your Watch List?

New 90-day low: €8.75

Gr. Sarantis S.A. to Report Fiscal Year 2020 Results on Apr 08, 2021

Vice Chairman & CEO recently bought €96k worth of stock

I Built A List Of Growing Companies And Gr. Sarantis (ATH:SAR) Made The Cut

Kyriakos Sarantis Is The Vice Chairman & CEO of Gr. Sarantis S.A. (ATH:SAR) And Just Spent €118k On Shares

Vice Chairman & CEO recently bought €118k worth of stock

Is Gr. Sarantis S.A. (ATH:SAR) A Great Dividend Stock?

Will The ROCE Trend At Gr. Sarantis (ATH:SAR) Continue?

Who Has Been Selling Gr. Sarantis S.A. (ATH:SAR) Shares?

Vice Chairman & CEO recently bought €51k worth of stock

What Does Gr. Sarantis S.A.'s (ATH:SAR) Share Price Indicate?

Mehmet Yigit Sardan will acquire 15% interest in Sarantis Anadol from Sarantis.

Gr. Sarantis S.A. Not to Provide Financial Guidance for the Fiscal Year of 2020

First half earnings released

Gr. Sarantis S.A. to Report First Half, 2020 Results on Sep 02, 2020

Gewinn- und Umsatzwachstumsprognosen

Analystenprognosen zum zukünftigen Wachstum

Wachstumsprognosen für den Gewinn je Aktie